suPAR

7 February, 2024

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

2024-02-07T15:45:40+03:00By hiss|Categories: Biomarkers, Publications|Tags: meropenem, qSOFA, Sepsis, suPAR|

Maria Evangelia Adami, Antigone Kotsaki, Nikolaos Antonakos, Efthymia Giannitsioti, Stamatios Chalvatzis, Maria Saridaki, Christina Avgoustou, Karolina Akinosoglou, Konstantina Dakou, Georgia Damoraki, Konstantina Katrini, Panagiotis Koufargyris, Vasileios Lekakis, Antonia Panagaki, Asimina Safarika, Jesper Eugen‐Olsen and Evangelos J. Giamarellos-Bourboulis Critical Care volume 28, Article number: 42 (2024) DOI: 10.1186/s13054-024-04825-2Download pdf 🡇 Funding The

27 December, 2022

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial

2024-04-03T12:43:50+03:00By hiss|Categories: Publications, Therapeutics|Tags: Anakinra, clinical trial, COVID-19, suPAR|

Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios

25 February, 2022

Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

2023-02-16T13:21:55+03:00By hiss|Categories: Publications|Tags: COVID-19, Sepsis, suPAR|

Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, Haralampos Milionis, Simeon Metallidis, Michalis Ploumidis, Pinelopi Grigoropoulou, Aggeliki Rapti, Francesco Vladimiro Segala, Evangelos Balis, Efthymia Giannitsioti, Paola Rodari, Ilias Kainis, Zoi Alexiou, Emanuele Focà, Brollo Lucio, Nikoletta Rovina, Laura Scorzolini, Maria Dafni, Sofia Ioannou, Alessandro Tomelleri, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina

8 March, 2021

An open label trial of anakinra to prevent respiratory failure in COVID-19

2024-03-29T14:13:13+03:00By hiss|Categories: Multicenter studies in Greece, Publications, Therapeutics|Tags: Anakinra, COVID-19, suPAR|

Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, Eleni Karakike, Maria Saridaki, Georgia Loli, Aggelos Stefos, Danai Prasianaki, Sarah Georgiadou, Olga Tsachouridou, Vasileios Petrakis, Konstantinos Tsiakos, Maria Kosmidou, Vassiliki Lygoura, Maria Dareioti, Haralampos Milionis, Ilias C Papanikolaou, Karolina Akinosoglou, Dimitra-Melia Myrodia, Areti Gravvani, Aliki Stamou, Theologia Gkavogianni, Konstantina Katrini,

1 November, 2020

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI

2023-02-16T13:38:04+03:00By hiss|Categories: Publications|Tags: COVID-19, suPAR|

Tariq U Azam, Husam R Shadid, Pennelope Blakely, Patrick O'Hayer, Hanna Berlin, Michael Pan, Peiyao Zhao, Lili Zhao, Subramaniam Pennathur, Rodica Pop-Busui, Izzet Altintas, Jens Tingleff, Marius A Stauning, Ove Andersen, Maria-Evangelia Adami, Nicky Solomonidi, Maria Tsilika, Pinkus Tober-Lau, Eleni Arnaoutoglou, Verena Keitel, Frank Tacke, Athanasios Chalkias, Sven H Loosen, Evangelos J. Giamarellos-Bourboulis, Jesper

1 September, 2020

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

2024-03-29T13:39:01+03:00By hiss|Categories: Biomarkers, Publications|Tags: suPAR|

Dimitrios Velissaris, George Dimopoulos, John Parissis, Zoi Alexiou, Nikolaos Antonakos, Dimitrios Babalis, Styliani Gerakari, Vassileios Kaldis, Pantelis Koutoukas, Malvina Lada, Konstantinos Leventogiannis, Ioannis Pantazopoulos, Antonios Papadopoulos, Eftihia Polyzogopoulou, Charalambos Gogos, Apostolos Armaganidis, Evangelos J. Giamarellos-Bourboulis Infectious Diseases and Therapy 2020 Sep;9(3):407-416 DOI: 10.1007/s40121-020-00301-wDownload pdf 🡇 Funding The study was funded by the Hellenic

30 April, 2020

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

2023-02-16T14:29:21+03:00By hiss|Categories: Biomarkers, Publications|Tags: COVID-19, suPAR|

Nikoletta Rovina, Karolina Akinosoglou, Jesper Eugen-Olsen, Salim Hayek, Jochen Reiser, Evangelos J. Giamarellos-Bourboulis Critical Care 2020 Apr 30;24(1):187 DOI: 10.1186/s13054-020-02897-4View article 🡇 Funding The study was funded by unrestricted educational grants provided by the Hellenic Institute for the Study of Sepsis. Funds were also provided by Rush University Medical Center. Keywords: COVID-19;

1 November, 2016

Soluble urokinase plasminogen activator receptor informs on the progression course after multiple injuries

2023-02-16T15:18:46+03:00By hiss|Categories: Publications|Tags: Sepsis, suPAR|

Maria Patrani, Thomas Tsaganos, Katerina Kotzampassi, Michael Paraschos, Chrysostomos Katsenos, Evangelos J. Giamarellos-Bourboulis, Konstantinos Mandragos Biomarkers 2016 Nov;21(7):660-4 DOI 10.1016/j.cyto.2022.15611 View article 🡇 Funding The study was funded in part by (a) the Hellenic Institute for the Study of Sepsis; and (b) an unrestricted educational grant by ViroGates SA, Copenhagen,

1 February, 2015

Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma

2023-02-16T15:37:33+03:00By hiss|Categories: Other Grants, Publications|Tags: PhD, suPAR|

Athina Chounta, Christofer Ellinas, Vassiliki Tzanetakou, Fani Pliarhopoulou, Virginia Mplani, Angelos Oikonomou, Kostantinos Leventogiannis, Evangelos J. Giamarellos-Bourboulis Liver International 2015 Feb;35(2):601-7 DOI: 10.1111/liv.12705View article 🡇 Funding This study was funded by a kind donation of the Hellenic Institute for the Study of Sepsis. Keywords: early diagnosis; hepatocellular carcinoma; suPAR

8 August, 2012

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

2024-03-28T13:43:25+03:00By hiss|Categories: Biomarkers, Publications|Tags: Sepsis, suPAR|

Evangelos J. Giamarellos-Bourboulis, Anna Norrby-Teglund, Vassiliki Mylona, Athina Savva, Iraklis Tsangaris, Ioanna Dimopoulou, Maria Mouktaroudi, Maria Raftogiannis, Marianna Georgitsi, Anna Linnér, George Adamis, Anastasia Antonopoulou, Efterpi Apostolidou, Michael Chrisofos, Chrisostomos Katsenos, Ioannis Koutelidakis, Katerina Kotzampassi, George Koratzanis, Marina Koupetori, Ioannis Kritselis, Korina Lymberopoulou, Konstantinos Mandragos, Androniki Marioli, Jonas Sundén-Cullberg, Anna Mega, Athanassios Prekates, Christina